García-Gutiérrez, Valentin
Breccia, Massimo
Jabbour, Elias
Mauro, Michael
Cortes, Jorge E.
Funding for this research was provided by:
Bristol Myers Squibb, United States
Article History
Received: 10 March 2022
Accepted: 2 June 2022
First Online: 11 July 2022
Declarations
:
: Not applicable.
: Not applicable.
: VGG Grants: Bristol Myers Squibb, Incyte, Novartis, Pfizer. Consulting fees: Bristol Myers Squibb, Incyte, Novartis, Pfizer. Payment/honoraria: Bristol Myers Squibb, Incyte, Novartis, Pfizer. Travel support: Bristol Myers Squibb, Incyte, Novartis, Pfizer. Data safety monitoring committee or advisory board: Bristol Myers Squibb, Incyte, Novartis, Pfizer. Leadership: Board of GELMC. MB Consulting: Bristol Myers Squibb/Celgene, Incyte, Novartis, Pfizer. EJ Research funds: AbbVie, Amgen, Bristol Myers Squibb, Pfizer, Takeda. Consultancy: AbbVie, Amgen, Bristol Myers Squibb, Genentech, Novartis, Pfizer, Takeda. MM Grants: Bristol Myers Squibb, Novartis, Sun Pharma/SPARC. Consulting fees: Bristol Myers Squibb, Novartis, Pfizer, Takeda. Payment/honoraria: Bristol Myers Squibb, Novartis, Pfizer, Takeda. Travel support: Bristol Myers Squibb, Novartis, Pfizer, Takeda. JC Grants: Bristol Myers Squibb, Novartis, Pfizer, Sun Pharma, Takeda. Consultancy: Novartis, Pfizer, Sun Pharma, Takeda.